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Introduction 
DĞĚŝĐĂƚŝŽŶƐƉƌĞƐĐƌŝďĞĚ ?ĚŝƐƉĞŶƐĞĚĂŶĚŚĞůĚŝŶĂƉĂƚŝĞŶƚ ?ƐŚŽŵĞŝŶĂŶƚŝĐŝƉĂƚŝŽŶŽĨŶĞĞĚĂƌĞ
becoming increasingly used in the UK (Wilcock, 2011) ?dŚĞƐĞ ?ũƵƐƚŝŶĐĂƐĞ ?Žƌ ?ĂŶƚŝĐŝƉĂƚŽƌǇ ?
medications can be prescribed in advance to manage common symptoms at the end of life including 
pain, nausea and vomiting, anxiety and excessive secretions. They are usually prescribed by a GP, 
dispensed and then heůĚŝŶƚŚĞƉĂƚŝĞŶƚ ?ƐŚŽŵĞŽƌŶƵƌƐŝŶŐŚŽŵĞĨŽƌƵƐĞŝĨĂŶĚǁŚĞŶŶĞĞĚĞĚ ?,ĂǀŝŶŐ
immediate access to necessary medications in the home is regarded as a key means of improving  
symptom management and enabling better end of life care in the community (Carney, 2011, Lawton 
et al., 2012, Faull et al., 2013, National Institute for Health and Care Excellence, 2015).  
 
Anticipatory prescribing is seen as enabling professional staff such as community and district nurses 
ƚŽƌĞƐƉŽŶĚŝŵŵĞĚŝĂƚĞůǇƚŽƉĂƚŝĞŶƚƐ ?ŶĞĞĚƐ(Carney, 2011 Ɖ ? ? ? ?zĞƚůŝƚƚůĞŝƐŬŶŽǁŶĂďŽƵƚŶƵƌƐĞƐ ?ƌŽůĞs 
and experiences in anticipatory prescribing (Wilson and Seymour, 2013, Eisenhauer et al., 2007) and 
it is cited as a recommended area of research in the new NICE guideline on caring for the dying 
(National Institute for Health and Care Excellence, 2015). A synthesis of the existing related research 
suggests that nurses may be challenged by a lack of resources, limited knowledge and experience 
with the relevant medications and power differentials between themselves and medical 
practitioners (Wilson and Seymour, 2013). Although local audits have been carried out to assess the 
implementation of anticipatory prescribing (Carney, 2011, Carney and MacRobbie, 2008, Scott-Aiton, 
2009, Amass and Allen, 2005, Lawton et al., 2012), there are no larger scale studies in existence.  
 
Insights from a qualitative study by Faull et al. (2013) suggest that anticipatory prescribing is 
complex and that health care staff have a range of interpretations of what is meant by prescribing in 
advance. The authors conclude that anticipatory prescribing is a process rather than a one-off event 
and highlight the need to build relationships between professionals to ensure good communication 
between teams and across organisational boundaries, including out-of-hours care.  
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This paper reports the findings of a survey that elicited the views of 575 community/district, nursing 
home, and palliative care nurses from two UK regions: the East Midlands and Lancaster/South 
Cumbria. The aim of the survey was to gain insight into the roles and experiences of a wide range of 
community nurses in end of life medication decisions. This paper draws on both quantitative and 
qualitative aspects of the survey to give an overview of the key findings. 
 
Methods 
The survey was part of a three phase mixed methods study to examine commƵŶŝƚǇŶƵƌƐĞƐ ?
experiences of working with anticipatory prescriptions. Phase one was a literature review of 26 
studies from 10 countries (Wilson and Seymour, 2013).  Phase two was a qualitative ethnographic 
study using interviews and observations (Wilson et al., 2015, Wilson et al., 2014). The survey was the 
third phase of the study, informed by the data gathered in the literature review and ethnography. 
The survey questionnaire was developed by the research team supported by an advisory panel with 
expertise in community and end of life care nursing. A face validity exercise was undertaken with a 
group of district nurses from the East Midlands. The nurses completed the survey and gave feedback 
in a focus group on the wording, style, order and appropriateness of the questions. In light of their 
comments, adjustments were made to the questionnaire. 
Survey sample 
The survey was conducted in two regions: East Midlands and Lancaster/South Cumbria. dŚĞŝŶůĞǇ ?Ɛ
database of NHS staff was used to select 500 district and community nurses at random in each area. 
In addition all specialist palliative care nurses, Macmillan and Marie Curie nurses1 and managers and 
matrons of nursing homes were also selected in the two areas. It was recognised that the database 
would not be completely up to date and search terms might identify some nurses who were not 
working in the fields required. In order to minimise the number of questionnaires sent to 
                                                          
1 'ƌŽƵƉĞĚĂŶĚƌĞĨĞƌƌĞĚƚŽĂ ?WĂůůŝĂƚŝǀĞĐĂƌĞŶƵƌƐĞƐ ? 
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inappropriate people, the lists were all examined by hand by the study team. During this process job 
and institutional titles were inspected to exclude individuals who were not likely to be involved in 
caring for adults who had died at home or in a nursing home. For example, we excluded all those 
located in hospitals or with job titles that would not have a primary focus on palliative care for 
adults. 
Data collection and management 
From February to May 2013 a postal questionnaire and two reminders were sent to 1739 individuals. 
181 mailings were returned as the individual no longer worked at the institution concerned, leaving 
a total valid sample of 1558. As questionnaires were returned the data were logged in a database 
managed through the programme Statistical Package for the Social Sciences (SPSS)©.  
Data analysis 
Survey data were analysed to produce a series of descriptive statistics supported by the SPSS 
software. Responses were compared across the three categories of nurses (nursing home nurses, 
community/district nurses and palliative care nurses). The free text sections were analysed using a 
thematic analysis (Braun and Clarke, 2006) to allocate codes to the comments made in order to 
identify patterns. These codes were then grouped and distilled to generate themes. Themes were 
then compared with the quantitative findings and are used in this paper to add depth. As not all 
respondents answered all questions, total response rates for individual questions are reported and 
vary throughout the paper. 
Ethical approval 
We obtained ethical approval from the National Research Ethics Service (11/EM/0213) and 
governance approval from the NHS Trusts at each research site. 
 
Findings 
The overall response rate was 37% (n=575/1558). While nursing home nurses (49.6%; n=231/466) 
and palliative care nurses (47.4%; n=151/318) responded well, a lower response from 
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community/district nurses (24.9%; n=193/774) reduced the overall response rate. Comparing the 
two regions, the East Midlands had a slightly better response rate (39.7%; n=380/957) compared to 
Lancaster/South Cumbria (32.4%; n=195/601). Respondents were predominantly female (95%; 
n=540/569), had worked as a nurse for 20 years or more (64%; n=366/572) and were likely to have 
some kind of additional training in palliative (70%; n=404/575) and/or end of life care (78%; 
n=440/575). Respondents reported attending a range of courses and training therefore it was not 
possible to compare the level or quality of the training reported. From the written comments those 
with additional qualifications appeared to value this training vis à vis the anticipatory prescribing 
process. Some of those with a prescribing qualification acknowledged that they could take on the 
prescription writing role in the process: 
Community/district nurses know more about end of life drugs and care than GPs. 
Consequently the decision to prescribe generally is dictated by the nurse and the GP will take 
their advice. Hopefully all nurses will hold NISP (V300) [Nurse Independent and 
Supplementary Prescribers] qualification soon and prescribe for patients. (184: District nurse 
team leader) 
I feel that as a NISP [Nurse Independent and Supplementary Prescribers] I am extremely 
confident in prescribing for palliative care patients, specifically in end of life care. (1204: 
Palliative care nurse) 
 
Caring for patients at the end of life 
Respondents were asked how many patients they cared for at the end of life in the past year. Overall 
83.7% (n=481/575) reported providing care to at least one person who had died in the past year. Of 
these 481 nurses, 471 (98.1%) reported that ĂŶ ?an anticipatory prescription for drugs aimed at 
ƌĞůŝĞǀŝŶŐƐǇŵƉƚŽŵƐĂŶĚĚŝƐƚƌĞƐƐ ? was in place for at least one patient. 98.3% (n=463/471) of 
respondents reporting this said that, in at least one case, these prescriptions were used. 
Respondents reporting that in no cases were they used (just 8 respondents) worked in care homes 
ŽƌŝŶ ?ŽƚŚĞƌ ?ƌŽůĞƐ ? 
Characteristics of patients where an anticipatory prescription was used 
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Having answered some general questions about anticipatory prescriptions, respondents were then 
asked to recall details of one specific patient for whom an anticipatory prescription had been used 
and to answer a series of further questions about that particular case. Table 1 gives a breakdown of 
the characteristics of these individual patient cases. tŚĞƌĞƉĂƚŝĞŶƚƐ ?ĂŐĞĐĂƚĞŐŽƌǇǁĂƐƌĞƉŽƌƚĞĚ
(n=412), 63.8% (n=263) were said to be aged 70 or over. The majority of the patients  for whom the 
use of an anticipatory prescription was recalled were reported by nurses as dying  in their own home 
or care home (96.4%; n=432/448). A primary cause of death was provided for 434 patient cases and 
in 79.3% (n=344/434) of these, cancer was reported by nurses as the registered cause of death.  
Fewer respondents from nursing homes reported that cancer was a cause of death among the 
patients whom they recalled as receiving anticipatory medications.  
Table 1 - Characteristics of patient cases reported by nurses to have received anticipatory prescription medications  
Characteristic 
Number of patient cases 
as reported by nurse 
respondents (%) 
Gender Male 194/442 (43.9%) 
Female 248/442 (56.1%) 
Age Under 50 32/412 (7.7%) 
50-69 117/412 (28.4%) 
70-89 263/412 (63.9%) 
Place of death Hospital 4/448 (0.9%) 
Hospice 12/448 (2.7%) 
Nursing/care home 198/448 (44.2%) 
Own home 234/448 (52.2%) 
Cause of death Cancer 344/434 (79.3%) 
Heart disease 27/434 (6.2%) 
Stroke 12/434 (2.8%) 
Other 51/434 (11.8%) 
 
 
The writing and dispensing of the medications 
In general, nurses reported working well with GPs and perceived that they had good access to the 
medications needed. Figure 1 shows that 79.2% (n=427/539) of nurses reported that they 
 ?ŝŶĨƌĞƋƵĞŶƚůǇŽƌŶĞǀĞƌ ?ĨŽƵŶĚĚŽĐƚŽƌƐƌĞůƵĐƚĂŶƚƚŽƉƌĞƐĐƌŝďĞĂŶƚŝĐŝƉĂƚŽƌǇŵĞĚŝĐĂƚŝŽŶĂŶĚ ? ? ? ?й
(n= ? ? ? ? ? ? ?ƌĞƉŽƌƚĞĚƚŚŝƐĂƐ ?ŶĞŝƚŚĞƌĨƌĞƋƵĞŶƚŶŽƌŝŶĨƌĞƋƵĞŶƚ ? ?However, it was evident there was 
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some variation. A small proportion, 9.6% (n=52/539), agreed that some doctors were reluctant to 
provide anticipatory prescriptions (see Figure 1) and this point was reflected in the qualitative 
comments: 
I work with different GP practices. All very individual, some more knowledgeable than others. 
Some happy to listen to nursing home staff and families and take our opinions on board. I 
have to get assistance from palliative care nurse at times to help me get GP to prescribe.  
(1273: Matron in a nursing home) 
The difficulty I found is that not all practices in my location are happy to prescribe 
anticipatory medications as they feel this is a waste on their budget and feel that out of 
hours doctors are there to be called upon for the prescribing of anticipatory drugs.  In the 
main the reluctance of GPs in prescribing is improving (1636: Manager in a nursing home) 
Similarly, a few nurses (8.6%; n=45/525) said that they  ?always or frequently ? experienced significant 
difficulties in obtaining the drugs specified in anticipatory prescriptions used in end of life care. For a 
further 11.2% (n= ? ? ? ? ? ? ?ƚŚŝƐǁĂƐƌĞƉŽƌƚĞĚĂƐ ?ŶĞŝƚŚĞƌĨƌĞƋƵĞŶƚŶŽƌŝŶĨƌĞƋƵĞŶƚ ?.  However the 
majority of nurses (80.2%; n=421/525) said they encountered these difficulties  ?ŝŶĨƌĞƋƵĞŶƚůǇŽƌ
ŶĞǀĞƌ ? ?ƐĞĞĨŝŐƵƌĞ ? ? ? 
 
Figure 1 - Prescription writing (539 responses) 
 
9.6% (n=52) 11.1% 
(n=60)
79.2% 
(n=427)
'Doctors with whom I work are reluctant to 
provide anticpatory prescritions for drugs used 
in end of life care'
Always or
frequently
Neither frequent
nor infrequent
Infrequently or
never
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Figure 2 ʹ Dispensing (525 responses) 
Across the three categories of nurses slightly less than one fifth (18.4%; n=97/527) agreed with the 
ƐƚĂƚĞŵĞŶƚ ?anticipatory prescriptions are incorrectly written up by doctors ? ?,ŽǁĞǀĞƌ ?ǁŚĞŶůŽŽŬŝŶŐ
at the categories of respondents this was reported more frequently by palliative care nurses (24.3%; 
n=28/115) and community/district nurses (25.7%; n=45/175) than by nursing home nurses (9.7% 
n=19/195). Comments about these issues were also added in the written section of the survey: 
I have real problems with GPs prescribing [end of life] drugs, they are usually unable to 
estimate doses correctly, have no idea how to prescribe when a patient has a Fentanyl patch 
ŽƌŽŶĂƐůŽǁƌĞůĞĂƐĞŵŽƌƉŚŝŶĞ ? ?dŚŝƐǁĞĞŬĞŶĚŽŶŽŶĞĚĂǇ ?ƉƌĞƐĐƌŝƉƚŝŽŶƐǁĞƌĞǁƌŝƚƚĞŶ
incorrectly.  (1019: Palliative care nurse) 
 
Anticipatory medications used 
Where respondents reported on the care of one specific patient who had been in receipt of 
anticipatory medications, Midazolam was the drug most commonly reported to have been used in 
the last month of life of this specific patient. This applied to 81.9% (n=367/448) of the patients 
where a use of an anticipatory prescription was recalled by nurses. This was followed by 
Levomepromazine (32.5%; n=143/440) and then Haloperidol (23.9%; n=104/435). Figure 3 shows the 
percentage of drugs used by category of respondent; nurses in all three categories reported similar 
patterns of usage. 
8.6% (n=45) 11.2% 
(n=59)
80.2% 
(n=421)
'I have experienced significant difficulties in 
obtaining the drugs specified in anticipatory 
prescriptions used in end of life care'
Always of
Frequently
Neither frequently
nor infrequently
Infrequently or
never
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Figure 3 - Drugs used by respondent category 
Managing the use of anticipatory medications 
Having the confidence to make decisions relating to the use of drugs specified in anticipatory 
prescriptions was considered to be important by 92.0% (n=483/525) of nurses responding to the 
survey. For example, when reporting the use of Midazolam in specific patient cases, 82.2% 
(n=287/349) of the responding nurses felt they had the responsibility of the assessing that ƉĂƚŝĞŶƚƐ ?
response to the drug. 34.1% (n=119/349) of nurses responding to this question about a specific 
patient care felt this responsibility lay with the GP, and 3.2% (n=11/349) with the specialist palliative 
care doctor (for this question respondents had the opportunity to select more than one option).  
Table 2 shows that for these patient cases medications were eitheƌ ?ŶŽƚŝŶĐƌĞĂƐĞĚ ?ŽƌũƵƐƚ ?ŝŶĐƌĞĂƐĞĚ 
gradualůǇ ? over the last three days of life, with a  ?strong increase ? on the last day being rare.  
Table 2 ʹ Reported changes in dosages for individual patient cases in the last three days of life  
 Midazolam Haloperidol Levomepromazine 
No increase 51.1% (n=165)  54.0% (n=47) 55.2% (n=69) 
Gradual increase 42.1% (n=136) 41.4% (n=36) 40.0% (n=50) 
Strong increase 
last day 
6.8% (n=22) 4.6% (n=4) 4.8% (n=6) 
TOTAL (=100%)* 323 87 125 
*Patients may have received more than one of these drugs 
Nurses reported that the anticipatory medications successfully controlled those symptoms they 
were intended to relieve in 89.6% of the patient cases they recalled. In a more general sense, most 
0%
10%
20%
30%
40%
50%
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Specialist Pallaitive Care
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respondents (96.0%; n=504/525) agreed that when anticipatory prescriptions were in place they 
 ?always or frequently ? enabled them to improve the quality of end of life care they provided: 
It helps to provide better quality of care for the patients, especially out of hours. (482: District 
nurse) 
Anticipatory prescribing is essential- whilst medications are not always needed it gives peace 
of mind to the resident, relatives and staff that, should symptoms develop, medication is at 
hand to deal with them. Proactive decision making is essential in this area. (1473: Matron in 
a nursing home) 
 
Discussion 
dŚŝƐƉĂƉĞƌŚĂƐƌĞƉŽƌƚĞĚŽŶŽŶĞĂƐƉĞĐƚŽĨĂǁŝĚĞƌƐƚƵĚǇƚŽĞǆƉůŽƌĞƚŚĞŶƵƌƐĞƐ ?ƌŽůĞƐŝŶƚŚĞƵƐĞŽĨ
anticipatory prescriptions. A survey was used to elicit views from 575 community/district, nursing 
home, and palliative care nurses across two regions in England. Initially nurses were asked to report 
their views about anticipatory prescribing in general; they were then asked to refer to a specific 
patient  whom they recalled had received anticipatory medications and to answer a series of further 
questions about that patient. The survey shows that nurses report the presence of anticipatory 
prescriptions as very common indeed. Moreover, when in place these prescriptions were normally 
used ?/ŶůŝŶĞǁŝƚŚĂƌŶĞǇ ?Ɛ(2011) ĂƵĚŝƚŽĨƚŚĞƵƐĞŽĨ ?ũƵƐƚŝŶĐĂƐĞ ?ďŽǆĞƐŝŶ^ĐŽƚůĂŶĚ ?ƚŚĞŵĂũŽƌŝƚǇŽĨ
nurses felt that having anticipatory medications in place enabled them to provide better care and 
could improve the quality of death.  
 
Our findings indicate that nurses have a number of pivotal and complex roles throughout the 
 ?ƉƌŽĐĞƐƐ ?ŽĨĂŶƚŝĐŝƉĂƚŽƌǇƉƌĞƐĐƌŝďŝŶŐ(Faull et al., 2013). The survey findings support those of the 
qualitative work undertaken in the earlier part of the study  and reported elsewhere (Wilson et al., 
2015), and was designed to indicate the prevalence of the issues raised by nurses.  
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Our findings give some insight into the types of medication used for symptom management and the 
pattern of their use.   Of the 441 specific cases where nurses recalled that a patient had received 
anticipatory medications, Midazolam was reported as the most commonly used drug, with 
Levomepromazine and then Haloperidol used less often. These are often considered to be three of 
ƚŚĞ ?ĐŽƌĞ ?ĚƌƵŐƐĐŽŵŵŽŶůǇƵƐĞĚŝŶĂŶƚŝĐŝƉĂƚŽƌǇƉƌĞƐĐƌŝƉƚŝŽŶƐ(Wilcock, 2011). For the individual 
cases reported it was rare for nurses to recall any  sudden increase in dosage of the medications 
used in the last three days of life;  any increases that were recalled were  considered by respondents 
as  ?ŐƌĂĚƵĂů ? ? 
 
Nurses responding to the survey reported a particular responsibility for monitoring the results of 
giving the medications, with GPs and other doctors were less often involved in this. This echoed 
narratives from nurses in the ethnographic element in phase two of the study, recounting that 
decisions about the use of anticipatory medications were primarily regarded to be the responsibility 
of the health care team, and often that of the nurse (Wilson et al., 2015).  
 
Although for the most part nurses reported that relationships with doctors were working well, a 
small proportion of respondents reported difficulties, again echoing findings from the ethnography 
in phase two of the study (Wilson et al., 2015). Some encountered reluctance in some doctors to 
provide anticipatory prescriptions. In addition a small number of respondents stated the 
effectiveness of the process could be challenged by prescriptions that were incorrectly written up by 
doctors, or by difficulties in obtaining the drugs. These findings resonate with observations by Faull 
et al. (2013) that there is potential for the process to stall at any stage. Recent guidance from NICE 
(National Institute for Health and Care Excellence, 2015) suggests that when considering the need 
for anticipatory medications clinicians should not only weigh up benefits and harms of prescribing in 
advance, but also recognise the possibility of sudden deterioration and time it might take to obtain 
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medications. Hence the recommendation is that prescriptions be put in place as early as possible, 
yet remain under review (National Institute for Health and Care Excellence, 2015).  
 
A small number of qualitative comments by responding nurses indicated that they valued being a 
nurse prescriber and that this had enhanced their confidence and capacity to provide good care. 
tĞďďĂŶĚ'ŝďƐŽŶ ?Ɛ(2011) audit of nurse independent prescribers supports this, concluding that 
prescribing by nurses is effective, timely and appropriate, especially during out-of-hours periods. 
 
Limitations 
^ŝŶĐĞ ? ? ? ? ? ? ? ? ? ? ? ? ?й ?ŽĨƚŚĞƋƵĞƐƚŝŽŶŶĂŝƌĞƐƐĞŶƚƚŽƉĞŽƉůĞůŝƐƚĞĚďǇŝŶůĞǇ ?ƐǁĞƌĞƌĞƚƵƌŶĞĚĂƐƚŚĞ
person had moved on since the list was compiled, it seems likely that the response was somewhat 
skewed towards nurses with more experience, as this statistiĐƐƵŐŐĞƐƚƐĂƚŝŵĞůĂŐďĞĨŽƌĞŝŶůĞǇ ?Ɛ
picks up a name and adds it to their database. If true, there would tend to be an under-
representation of people recently starting in posts, and this group may be more likely to contain 
nurses who had not worked in the role before. A high proportion of respondents with twenty years 
or more experience may also indicate that the questionnaire was passed on to nurses with more 
experience to complete and/or that more experienced nurses were more likely to deal with patients 
with anticipatory prescriptions in place.  
 
The survey was sent to nurses at a time when end of life care was under a great deal of scrutiny due 
to a media furore and the subsequent repeal of the Liverpool Care Pathway 
(https://www.gov.uk/government/publications/review-of-liverpool-care-pathway-for-dying-
patients);  this may have led to some nurses being reluctant to share their experiences of using 
anticipatory medications at the end of life, resulting in a lower response rate, particularly from 
community/district nurses. 
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It is important for the reader to note that we did not have direct access to patient data. Nurses were 
asked to report on one specific case with which they had been involved, we therefore have no 
ŬŶŽǁůĞĚŐĞŽĨŚŽǁƌĞƉƌĞƐĞŶƚĂƚŝǀĞƚŚŝƐĐĂƐĞŵĂǇŚĂǀĞďĞĞŶŽĨƚŚĂƚƌĞƐƉŽŶĚĞŶƚ ?ƐĐĂƐĞůŽĂĚ, or how 
accurate was their reporting of medication use.  
 
Conclusion 
The survey was able to gain insight into the roles and experiences of a substantial number, and 
range of nurses working with end of life medications in the community. Survey responses show that 
anticipatory prescriptions are very common, and once in place are often used. The comments in the 
survey show that nurses value the provision of anticipatory prescriptions and in general believe 
them to improve the care they provide for their patients. Although for the most part the 
relationships with doctors were reported by the nurse respondents as working well, a small 
proportion recorded difficulties when some doctors were reluctant to provide prescriptions, when 
prescriptions were incorrectly written up by doctors, or in obtaining drugs. This suggests 
pharmacists, nurses and GPs need to work together to establish the most appropriate ways of 
facilitating this process. In qualitative comments several nurses indicated that they valued being a 
nurse prescriber and that this enhanced their confidence and capacity to provide good care. 
Increasing the number of Nurse Independent and Supplementary Prescribers (NISP) may help to 
support the process of anticipatory prescribing.  
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